Dashboard
1
High Management Efficiency with a high ROCE of 78.89%
2
Company has a low Debt to Equity ratio (avg) at times
3
Poor long term growth as Net Sales has grown by an annual rate of 10.30% over the last 5 years
4
The company has declared Positive results for the last 4 consecutive quarters
5
With ROE of 28.73%, it has a attractive valuation with a 2.80 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.36%
0%
21.36%
6 Months
23.76%
0%
23.76%
1 Year
-14.68%
0%
-14.68%
2 Years
187.36%
0%
187.36%
3 Years
197.62%
0%
197.62%
4 Years
208.64%
0%
208.64%
5 Years
488.24%
0%
488.24%
Biorem, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
40.63%
EBIT to Interest (avg)
2.92
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
2.91
Tax Ratio
26.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
78.89%
ROE (avg)
37.65%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
2.80
EV to EBIT
5.66
EV to EBITDA
5.02
EV to Capital Employed
4.57
EV to Sales
0.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
80.66%
ROE (Latest)
28.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
9.40
7.30
28.77%
Operating Profit (PBDIT) excl Other Income
1.20
0.60
100.00%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.70
0.30
133.33%
Operating Profit Margin (Excl OI)
112.20%
70.30%
4.19%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 28.77% vs 69.77% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 133.33% vs 400.00% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
37.40
25.20
48.41%
Operating Profit (PBDIT) excl Other Income
4.90
3.50
40.00%
Interest
0.20
0.30
-33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.00
2.20
36.36%
Operating Profit Margin (Excl OI)
117.40%
122.60%
-0.52%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 48.41% vs -12.80% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 36.36% vs 37.50% in Dec 2023
About Biorem, Inc. 
Biorem, Inc.
Industrial Manufacturing
Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). The Company operates through the manufacture and sale of air pollution control systems segment. The Company also offers Biogas Conditioning technologies specializing in biological treatment of hydrogen sulfide. The Company's product solutions include biofilters, biotrickling filters, multi-stage systems, biogas solutions, organics and anaerobic digestion, SK series and engineered media. The Company's service solutions include biological processes and testing, media sampling and analysis, full system review and inspections, and media replacements and spare parts. The Company has over 1,000 installed systems around the world.
Company Coordinates 
Company Details
7496 Wellington Road 34, Rr 3 , GUELPH ON : N1H 6H9
Registrar Details






